When Radius Health scored an early approval for its osteoporosis med Tymlos last month, industry watchers thought it wouldn't be long before the drug had to contend with another newcomer from Amgen.
Please provide your email address to receive an email when new articles are posted on . Gains in ultradistal radius bone mineral density demonstrated by postmenopausal women with osteoporosis who had ...
Analysts expected Eli Lilly’s Forteo to be the big challenge standing in the way of new Radius bone drug Tymlos. But Express Scripts apparently has other ideas. On Monday, the PBM giant said Forteo ...
WALTHAM, Mass., Oct. 10, 2015 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS) announces positive top-line data from the Phase 3 ACTIVE (Abaloparatide Comparator Trial In Vertebral Endpoints) ...
Thrombocytopenia-absent radius syndrome is a rare congenital condition. It causes a low platelet count and the absence of the radius bone in both forearms. Thrombocytopenia occurs when the number of ...
This study extends the literature that uses in HR pQCT to examine ''bone quality" in vivo in a novel way using customized image acquisition and analyses protocols to assess bone parameters in the ...
Please provide your email address to receive an email when new articles are posted on . Older men are more likely to have a fracture if they have a greater decline in cortical bone at the distal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback